Report
EUR 13.66 For Business Accounts Only

An unfavourable environment weighs on VITAMIN SHOPPE INCO., which sees a downgrade to Negative

The independent financial analyst theScreener just requalified the general evaluation of VITAMIN SHOPPE INCO. (US), active in the Specialty Retailers industry. As regards its fundamental valuation, the title still shows 1 out of 4 stars and its market behaviour is seen as risky. theScreener believes that the unfavourable environment weighs on the sector and penalises the company, which sees a downgrade to its general evaluation to Negative. As of the analysis date December 10, 2019, the closing price was USD 6.50 and its target price was estimated at USD 4.13.
Underlying
Vitamin Shoppe

Vitamin Shoppe is a retailer and contract manufacturer of vitamins, minerals, herbs, specialty supplements, sports nutrition and other health and wellness products. The company's product categories are: Vitamins, Minerals, Herbs and Homeopathy, which includes multi-vitamins such as Vitamins A, C, D, E, and B-complex, along with calcium, magnesium, chromium and zinc; Sports Nutrition, which include protein and weight gain powders, meal replacements, weight management, and pre and post-workout supplements; Specialty Supplements, which include organic greens, psyllium fiber and soy proteins; and Other, which include items such as on the go bars, drinks and snacks, natural beauty and personal care.

Provider
TheScreener
TheScreener

Empowering Investors

theScreener is the market leader for independent valuations of financial securities, equities, sectors and markets, and new funds. theScreener's ratings, analyses are used by leading banks, asset managers and financial portals.  Approximately 10,000 workstations benefit from theScreener's services, with over millions of customer accounts actively analysed.

  • Worldwide coverage: theScreener analyses cover around 6'500 Stocks, i.e 95% of the world Market Capitalization.  theScreener state of art: We provide
  • theScreener state of art: We provide easy to use and complete analyses over Stocks, including Fundamentals / Technical / Risk/ Peer / Alternatives analyses.
  • For Research Pool community, we provide twice a week around 500 new equity analyses. We produce analyses about equities which have been upgraded or downgraded

 

Other Reports on these Companies
Other Reports from TheScreener

ResearchPool Subscriptions

Get the most out of your insights

Get in touch